Investor Kempen Capital Management N.v.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Kempen Capital Management N.v. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-07 13G/A LXFR / Luxfer Holdings PLC 1,364,003 1,310,724
2025-05-13 13G/A THR / Thermon Group Holdings, Inc. 1,713,802 1,462,470
2025-05-13 13G/A LXFR / Luxfer Holdings PLC 1,885,818 1,364,003
2025-02-13 13G/A LXFR / Luxfer Holdings PLC 2,689,684 1,885,818
2025-02-13 13G/A THR / Thermon Group Holdings, Inc. 2,245,254 1,713,802
2024-02-12 13G/A LXFR / Luxfer Holdings PLC 1,966,622 2,689,684
2024-02-12 13G/A LXFR / Luxfer Holdings PLC 1,966,622 2,348,584
2024-02-12 13G/A THR / Thermon Group Holdings, Inc. 3,299,670 2,245,254
2024-02-12 13G/A SNBR / Sleep Number Corporation 1,242,742 949,668
2023-02-13 13G SNBR / Sleep Number Corporation 1,242,742
2023-02-13 13G LXFR / Luxfer Holdings PLC 1,999,576 1,966,622
2022-02-11 13G THR / Thermon Group Holdings, Inc. 2,350,105 3,299,670
2022-02-11 13G LXFR / Luxfer Holdings PLC 1,623,923 1,999,576
2021-02-12 13G THR / Thermon Group Holdings, Inc. 2,350,105
2021-02-12 13G LXFR / Luxfer Holdings PLC 1,623,923
2015-05-08 13G/A RNA / Avidity Biosciences, Inc. 0
2014-08-05 13G RNA / Avidity Biosciences, Inc. 1,996,253